🇺🇸 FDA
Patent

US 10117871

3-hydroxypyrimidine-2,4-dione-5-carboxamides as potent inhibitors of HIV

granted A61KA61K31/03A61K31/513

Quick answer

US patent 10117871 (3-hydroxypyrimidine-2,4-dione-5-carboxamides as potent inhibitors of HIV) held by Regents of the University of Minnesota expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/03, A61K31/513, A61P, A61P31/18